151 related articles for article (PubMed ID: 6504896)
21. The management of superficial transitional cell carcinoma of the bladder: a critical assessment of contemporary concepts and future perspectives.
Vögeli TA
BJU Int; 2005 Dec; 96(8):1171-6. PubMed ID: 16285875
[No Abstract] [Full Text] [Related]
22. Intravesical mitomycin C for superficial transitional cell carcinoma.
Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493
[TBL] [Abstract][Full Text] [Related]
23. Trimodality treatment and selective organ preservation for bladder cancer.
Rödel C; Weiss C; Sauer R
J Clin Oncol; 2006 Dec; 24(35):5536-44. PubMed ID: 17158539
[TBL] [Abstract][Full Text] [Related]
24. Radiochemotherapy after transurethral resection is an effective treatment method in T1G3 bladder cancer.
Akçetin Z; Todorov J; Tüzel E; Engehausen DG; Krause FS; Sauer R; Schrott KM; Rödel C
Anticancer Res; 2005; 25(3A):1623-8. PubMed ID: 16033071
[TBL] [Abstract][Full Text] [Related]
25. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ
J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
[TBL] [Abstract][Full Text] [Related]
26. [Prevention of the recurrence of bladder tumors with local adriamycin therapy].
Somogyi L; Török A; Bors G; Frang D
Orv Hetil; 1984 Oct; 125(41):2503-6. PubMed ID: 6493764
[No Abstract] [Full Text] [Related]
27. Editorial: urothelial tumors--liberal applications of conservative approaches.
Droller MJ
J Urol; 2003 Mar; 169(3):936-7. PubMed ID: 12576816
[No Abstract] [Full Text] [Related]
28. [Dispensary observation of patients with urinary bladder tumors (according to materials from the N. N. Petrov Research Institute of Oncology of the MH of the USSR)].
Berman NA; Mirotvortseva KS
Vopr Onkol; 1972; 18(6):71-5. PubMed ID: 5042744
[No Abstract] [Full Text] [Related]
29. Recent advances in diagnosis and treatment of transitional cell carcinoma of the bladder.
Martyn-Hemphill C; Mak D; Khan MS; Challacombe BJ; Bishop CV
Int J Surg; 2013; 11(9):749-52. PubMed ID: 24013072
[TBL] [Abstract][Full Text] [Related]
30. [Results of therapy in different groups of risk for superficial bladder cancer].
Startsev VIu; Gorelov SI; Pulin IL; Merkur'eva RD; Ogava I
Vopr Onkol; 2006; 52(2):187-91. PubMed ID: 17195646
[TBL] [Abstract][Full Text] [Related]
31. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
Koch MO; Coussens D
Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
[No Abstract] [Full Text] [Related]
32. [Use of azauridine in cancer of the urinary bladder].
Erukhimov LS; Vermel' EM
Vopr Onkol; 1969; 15(5):91. PubMed ID: 5360151
[No Abstract] [Full Text] [Related]
33. [A case of transitional cell carcinoma of the bladder in a juvenile patient].
Koroku M; Tanda H; Kato S; Onishi S; Nakajima H; Nanbu A; Nitta T; Akagashi K
Hinyokika Kiyo; 1999 Oct; 45(10):711-2. PubMed ID: 10586365
[TBL] [Abstract][Full Text] [Related]
34. [Our experience in the treatment of superficial tumors of bladder with the binomial endoscopic surgery and local chemotherapy (adriamycin)].
Corredera Zambrana M; Galbis Palau F; Cáceres Gómez F
Actas Urol Esp; 1983; 7(6):427-32. PubMed ID: 6670611
[No Abstract] [Full Text] [Related]
35. Adjuvant chemotherapy for non-organ confined bladder transitional cell carcinoma.
Abi-Aad AS
Acta Urol Belg; 1996 May; 64(2):35-7. PubMed ID: 8701808
[No Abstract] [Full Text] [Related]
36. Topical instillation of doxorubicin hydrochloride in the treatment of recurring superficial transitional cell carcinoma of the bladder.
Banks MD; Pontes JE; Izbicki RM; Pierce JM
J Urol; 1977 Nov; 118(5):757-60. PubMed ID: 916094
[TBL] [Abstract][Full Text] [Related]
37. Future therapies for the treatment of bladder neoplasms.
See WA; Berman CJ
Semin Surg Oncol; 1997; 13(5):376-88. PubMed ID: 9259094
[TBL] [Abstract][Full Text] [Related]
38. [Only metastasis to uterine corpus from superficial bladder cancer that of no original recurrence].
Murakami T; Hoshino K; Hasumi H; Makiyama K; Miyoshi Y; Yoshida M; Nakaigawa N; Ogawa T; Uemura H; Yao M; Kubota Y
Hinyokika Kiyo; 2007 Jan; 53(1):75-7. PubMed ID: 17310775
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy agents in transitional cell carcinoma: the old and the new.
Maluf FC; Bajorin DF
Semin Urol Oncol; 2001 Feb; 19(1):2-8. PubMed ID: 11246730
[TBL] [Abstract][Full Text] [Related]
40. Combined treatment of advanced bladder carcinoma.
Bichler KH; Flüchter SH; Erdmann WD; Strohmaier WL; Steimann J
Recent Results Cancer Res; 1988; 107():222-5. PubMed ID: 2453903
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
